Author(s):
Vandana Patil, Krishna Chopde, Amruta Jadhav, Nilay Shinde
Email(s):
chopdekrishna205@gmail.com
DOI:
10.52711/2231-5659.2025.00032 
Address:
Vandana Patil1, Krishna Chopde2*, Amruta Jadhav2, Nilay Shinde2
1Professor, Yash Institute of Pharmacy, Chh. Sambhajinagar MS.
2Final Year B. Pharmacy Student, Yash Institute of Pharmacy, Chh. Sambhajinagar MS.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
This article explores nanosuspensions, a novel dosage form with potential for drug development. Nanosuspensions are effective due to their versatility and working systems, making them suitable for various dosages and carrier systems. The study explores various techniques like high-pressure homogenization, media milling, emulsification-solvent evaporation, precipitation, and supercritical fluid processes. It also discusses the flexibility of administration routes, including parenteral, peroral, ocular, and pulmonary routes. The article aims to simplify further research outcomes in nanosuspensions and provides a systematic understanding of its principles, preparation techniques, advantages, identification, protected inventions, commercial products, and applications.
Cite this article:
Vandana Patil, Krishna Chopde, Amruta Jadhav, Nilay Shinde. Advancements in Nanosuspensions: Bridging Nanotechnology with Medicine to Transform Drug Delivery by Nanonization for Bioavailability Boosting. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2):207-4. doi: 10.52711/2231-5659.2025.00032
Cite(Electronic):
Vandana Patil, Krishna Chopde, Amruta Jadhav, Nilay Shinde. Advancements in Nanosuspensions: Bridging Nanotechnology with Medicine to Transform Drug Delivery by Nanonization for Bioavailability Boosting. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2):207-4. doi: 10.52711/2231-5659.2025.00032 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-2-17
REFERENCES:
1. Alaei S, Ghasemian E, Vatanara A. Spray drying of cefixime nanosuspension to form stabilized and fast dissolving powder. Powder Technology [Internet]. 2016 Jan 1; 288:241–8. Available from: https://www.sciencedirect.com/science/article/pii/S003259101530139X
2. Rana P, Murthy RSR. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Drug Delivery [Internet]. 2013 Jun [cited 2024 Oct 9]; 20(5): 224–35. Available from: http://www.tandfonline.com/doi/full/10.3109/10717544.2013.779331
3. Sharma OP, Patel V, Mehta T. Design of experiment approach in development of febuxostat nanocrystal: Application of Soluplus® as stabilizer. Powder Technology. 2016 Nov 1; 302:396–405.
4. Zhang X, Zhao J, Guan J, Zhang X, Li L, Mao S. Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets. Journal of Drug Delivery Science and Technology [Internet]. 2019 Apr 1; 50: 107–12. Available from: https://www.sciencedirect.com/science/article/pii/S1773224718308311
5. Möschwitzer JP, Müller RH. Factors influencing the release kinetics of drug nanocrystal-loaded pellet formulations. Drug Development and Industrial Pharmacy [Internet]. 2013 May 1; 39(5): 762–9. Available from: https://doi.org/10.3109/03639045.2012.702347
6. Müller RH, Jacobs C. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. International Journal of Pharmaceutics [Internet]. 2002 Apr 26; 237(1): 151–61. Available from: https://www.sciencedirect.com/science/article/pii/S0378517302000406
7. Wang L, Du J, Zhou Y, Wang Y. Safety of nanosuspensions in drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine [Internet]. 2017 Feb 1; 13(2):455–69. Available from: https://www.sciencedirect.com/science/article/pii/S1549963416301150
8. Bucolo C, Maltese A, Puglisi G, Pignatello R. Enhanced Ocular Anti-Inflammatory Activity of Ibuprofen Carried by an Eudragit RS100® Nanoparticle Suspension. Ophthalmic Research [Internet]. 2002 Oct 11 [cited 2024 Oct 9]; 34(5): 319–23. Available from: https://doi.org/10.1159/000065608
9. Gigliobianco MR, Casadidio C, Censi R, Di Martino P. Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability. Pharmaceutics [Internet]. 2018 Aug 21 [cited 2024 Oct 9]; 10(3): 134. Available from: https://www.mdpi.com/1999-4923/10/3/134
10. Spreen W, Williams P, Margolis D, Ford SL, Crauwels H, Lou Y, et al. Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes [Internet]. 2014; 67(5). Available from: https://journals.lww.com/jaids/fulltext/2014/12150/pharmacokinetics, _safety, _and_tolerability_with.5.aspx
11. Du B, Shen G, Wang D, Pang L, Chen Z, Liu Z. Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats. Drug Delivery [Internet]. 2013 Jan [cited 2024 Oct 9]; 20(1):25–33. Available from: http://www.tandfonline.com/doi/full/10.3109/10717544.2012.742939
12. Ibrahim MA, Shazly GA, Aleanizy FS, Alqahtani FY, Elosaily GM. Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity. Saudi Pharmaceutical Journal [Internet]. 2019 Jan [cited 2024 Oct 9]; 27(1):49–55. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1319016418301592
13. Zhang Y, Zhang J. Preparation of budesonide nanosuspensions for pulmonary delivery: Characterization, in vitro release and in vivo lung distribution studies. Artificial Cells, Nanomedicine, and Biotechnology [Internet]. 2016 Jan 2 [cited 2024 Oct 9]; 44(1):285–9. Available from: https://www.tandfonline.com/doi/full/10.3109/21691401.2014.944645
14. Gao Y, Li Z, Sun M, Guo C, Yu A, Xi Y, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Delivery [Internet]. 2011 Feb [cited 2024 Oct 9]; 18(2): 131–42. Available from: http://www.tandfonline.com/doi/full/10.3109/10717544.2010.520353
15. Yin T, Cai H, Liu J, Cui B, Wang L, Yin L, et al. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. European Journal of Pharmaceutical Sciences [Internet]. 2016 Feb 15; 83: 79–87. Available from: https://www.sciencedirect.com/science/article/pii/S0928098715300932
16. Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. European Journal of Pharmaceutical Sciences [Internet]. 2005 Apr 1; 24(5): 441–9. Available from: https://www.sciencedirect.com/science/article/pii/S0928098705000278
17. Mandal B, Alexander K, Riga A. Preparation and physicochemical characterization of Eudragit® RL100 Nanosuspension with potential for Ocular Delivery of Sulfacetamide. Journal of Pharmacy & Pharmaceutical Sciences. 2010 Nov 13; 13:510.
18. Poster Session 1 — Drug Delivery. Journal of Pharmacy and Pharmacology [Internet]. 2004 Sep 1 [cited 2024 Oct 9]; 56(Supplement_1): 7–22. Available from: https://doi.org/10.1211/002235704777489375
19. Chonkar AD, Rao JV, Managuli RS, Mutalik S, Dengale S, Jain P, et al. Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. European Journal of Pharmaceutics and Biopharmaceutics [Internet]. 2016 Jun 1; 103: 179–91. Available from: https://www.sciencedirect.com/science/article/pii/S0939641116301254
20. Mou D, Chen H, Wan J, Xu H, Yang X. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. International Journal of Pharmaceutics [Internet]. 2011 Jul 15; 413(1): 237–44. Available from: https://www.sciencedirect.com/science/article/pii/S0378517311003619
21. Ghosh I, Michniak-Kohn B. Influence of Critical Parameters of Nanosuspension Formulation on the Permeability of a Poorly Soluble Drug through the Skin—A Case Study. AAPS PharmSciTech [Internet]. 2013 Sep [cited 2024 Oct 9]; 14(3): 1108–17. Available from: http://link.springer.com/10.1208/s12249-013-9995-4
22. Piao H, Kamiya N, Hirata A, Fujii T, Goto M. A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium. Pharm Res [Internet]. 2008 Apr; 25(4): 896–901. Available from: http://europepmc.org/abstract/MED/17896098
23. Kumar S, Shen J, Burgess DJ. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole. Journal of Controlled Release [Internet]. 2014 Oct 28; 192:95–102. Available from: https://www.sciencedirect.com/science/article/pii/S0168365914004684
24. Bharti K, Mittal P, Mishra B. Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment. Journal of Drug Delivery Science and Technology [Internet]. 2019 Feb 1; 49: 420–32. Available from: https://www.sciencedirect.com/science/article/pii/S1773224718310773
25. Braig V, Konnerth C, Peukert W, Lee G. Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets. International Journal of Pharmaceutics [Internet]. 2019 Jan 10; 554: 54–60. Available from: https://www.sciencedirect.com/science/article/pii/S0378517318307348
26. Rajamani S, Sengodan T, Radhakrishnan A, Shanmukhan N. Pharmacokinetic and tissue distributions of naringenin and naringenin nanosuspension. Asian Journal of Pharmaceutics. 2018 Oct 1; 12: S1201–7.
27. Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. International Journal of Pharmaceutics [Internet]. 2008 Apr 16; 354(1): 227–34. Available from: https://www.sciencedirect.com/science/article/pii/S0378517307009994
28. Jun L, Min Y, Wen-Rong X. Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin. DDDT [Internet]. 2018 Oct [cited 2024 Oct 9]; Volume 12:3491–9. Available from: https://www.dovepress.com/enhanced-oral-bioavailability-of-fluvastatin-by-using-nanosuspensions--peer-reviewed-article-DDDT
29. Ahmadi Tehrani A, Omranpoor MM, Vatanara A, Seyedabadi M, Ramezani V. Formation of nanosuspensions in bottom-up approach: theories and optimization. DARU J Pharm Sci [Internet]. 2019 Jun [cited 2024 Oct 9]; 27(1):451–73. Available from: http://link.springer.com/10.1007/s40199-018-00235-2
30. Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. International Journal of Pharmaceutics [Internet]. 2006 Apr 7; 312(1):179–86. Available from: https://www.sciencedirect.com/science/article/pii/S0378517306000366
31. Ahmadi Tehrani A, Omranpoor MM, Vatanara A, Seyedabadi M, Ramezani V. Formation of nanosuspensions in bottom-up approach: theories and optimization. DARU J Pharm Sci [Internet]. 2019 Jun [cited 2024 Dec 1]; 27(1):451–73. Available from: http://link.springer.com/10.1007/s40199-018-00235-2
32. Zhang N, Wang, Li. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy. IJN [Internet]. 2012 Jun [cited 2024 Oct 9]; 3281. Available from: http://www.dovepress.com/folate-targeted-docetaxel-lipid-based-nanosuspensions-for-active-targe-peer-reviewed-article-IJN
33. Lai F, Pini E, Angioni G, Manca ML, Perricci J, Sinico C, et al. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics [Internet]. 2011 Nov 1; 79(3):552–8. Available from: https://www.sciencedirect.com/science/article/pii/S0939641111002116
34. Van ′T Klooster G, Hoeben E, Borghys H, Looszova A, Bouche MP, Van Velsen F, et al. Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation. Antimicrob Agents Chemother [Internet]. 2010 May [cited 2024 Oct 9]; 54(5):2042–50. Available from: https://journals.asm.org/doi/10.1128/AAC.01529-09
35. Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, et al. Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. European Journal of Pharmaceutical Sciences [Internet]. 2010 Jul 11; 40(4):325–34. Available from: https://www.sciencedirect.com/science/article/pii/S092809871000151X
36. Aldeeb M, Wilar G, Suhandi C, Elamin K, Wathoni N. Nanosuspension-Based Drug Delivery Systems for Topical Applications. IJN [Internet]. 2024 Jan [cited 2024 Dec 1]; Volume 19:825–44. Available from: https://www.dovepress.com/nanosuspension-based-drug-delivery-systems-for-topical-applications-peer-reviewed-fulltext-article-IJN
37. Vittal C. S. Formulation Strategies And Consideration In Nanosuspension Development: A Review. 2024 Oct 15 [cited 2024 Dec 1]; Available from: https://zenodo.org/doi/10.5281/zenodo.13936529
38. Tupe A, Mankar SD. Nanosuspension: A Novel Approach to Improve the Solubility, Bioavailability and Pharmacokinetics of Poorly Soluble Drugs. AJPT [Internet]. 2023 Aug 26 [cited 2024 Dec 1]; 194–200. Available from: https://ajptonline.com/AbstractView.aspx?PID=2023-13-3-8
39. Watanabe T, Ohno I, Wakiyama N, Kusai A, Senna M. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture. International Journal of Pharmaceutics [Internet]. 2002 Jul 8; 241(1):103–11. Available from: https://www.sciencedirect.com/science/article/pii/S0378517302001965
40. Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T, et al. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Advanced Drug Delivery Reviews [Internet]. 2007 Jul 10; 59(6):419–26. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X07000397
41. Möschwitzer J, Müller RH. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. European Journal of Pharmaceutics and Biopharmaceutics [Internet]. 2006 Apr 1; 62(3):282–7. Available from: https://www.sciencedirect.com/science/article/pii/S0939641105002511
42. Goel S, Sachdeva M, Agarwal V. Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations. DDF [Internet]. 2019 Aug 29 [cited 2024 Dec 1]; 13(2):91–104. Available from: http://www.eurekaselect.com/172570/article
43. Modh N, Mehta D, Parejiya P, Popat A, Barot B. An Overview of Recent Patents on Nanosuspension. DDF [Internet]. 2014 Jul 7 [cited 2024 Dec 1]; 8(2):144–54. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1872-2113&volume=8&issue=2&spage=144
44. I. Jethara S, D. Patel A, R. Patel M, S. Patel M, R. Patel K. Recent Survey on Nanosuspension: A Patent Overview. DDF [Internet]. 2015 Mar 3 [cited 2024 Dec 1]; 9(1):65–78. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1872-2113&volume=9&issue=1&spage=65
45. Gharge VS, Shinde MB, Pustake BD, Kinage KB, Kulkarni AA. Nanosuspensions: Recent Patents and Pharmaceutical Aspects as Drug Delivery Systems. PCI- Approved-IJPSN [Internet]. 2017 Mar 31 [cited 2024 Dec 1]; 10(2):3631–44. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/831
46. Goel S, Sachdeva M, Agarwal V. Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations. DDF [Internet]. 2019 Aug 29 [cited 2024 Dec 1]; 13(2):91–104. Available from: http://www.eurekaselect.com/172570/article
47. Goel S, Sachdeva M, Agarwal V. Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations. DDF [Internet]. 2019 Aug 29 [cited 2024 Dec 1]; 13(2):91–104. Available from: http://www.eurekaselect.com/172570/article
48. Teja PK, Mithiya J, Kate AS, Bairwa K, Chauthe SK. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview. Phytomedicine [Internet]. 2022 Feb [cited 2024 Dec 2]; 96:153890. Available from: https://linkinghub.elsevier.com/retrieve/pii/S094471132100430X
49. Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res [Internet]. 2020 Mar 20 [cited 2024 Dec 1]; 24(1):3. Available from: https://spj.science.org/doi/10.1186/s40824-020-0184-8